Mitotherapeutix, LLC — Form D/A
Mitotherapeutix, LLC of Woodbridge, CT, a company, filed a Form D amendment with the SEC on 2020-02-05. The offering totals $1.9M, of which $1.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-02-05
- Form: D/A
- Accession: 0001657701-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.9M
- Amount sold: $1.9M
- Investors: 5
- Date of first sale: 2017-12-12
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-301888
Issuer
- Name: Mitotherapeutix, LLC
- CIK: 0001657701
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 4 Research Drive, Woodbridge, CT, 06525
- Phone: 203-498-4411
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Robert V Hemley | Director | Cheshire, CT |
| Fenel V Eloi | Director | Woodbridge, CT |
| Robert Hemley | Director | Woodbridge, CT |
| Robert Hemley | Executive Officer | Woodbridge, CT |
| Robert Hennessey | Director | Woodbridge, CT |
| Robert Hennessey | Executive Officer | Woodbridge, CT |
| John V Talley | Director | Woodbridge, CT |
| John V Talley | Executive Officer | Woodbridge, CT |
| Daniel V Wagner | Director | Woodbridge, CT |
| John Talley | Director | Cheshire, CT |
| John Talley | Executive Officer | Cheshire, CT |
Other filings by this issuer (3)
More